Video
Marcelo Bigal, MD, PhD
Dr. Bigal discusses the findings from two phase IIb clinical trials of TEV-48125, a CGRP monoclonal antibody, for the preventive treatment of...
Video
Lars Edvinsson, MD, PhD
Dr. Edvinsson provides an overview of CGRP as a target for the treatment of migraine.
Next Article:
Related Articles
-
-
Audio
Stewart Tepper, MD, and Alan Rapoport, MD
At the 2015 HCOP conference, Dr. Tepper describes products in development that target CGRP to treat migraine.
